Picture of Evotec SE logo

EVT — Evotec SE News Story

0.000.00%
de flag iconLast trade - 00:00
HealthcareHighly SpeculativeMid CapNeutral

Brief: Evotec Receives $25 Mln Payment From Bristol Myers Squibb To Support Joint Programs

Oct 27 (Reuters) - EVOTEC SE EVTG.DE:

EVOTEC ANNOUNCES PROGRESS IN PRECLINICAL NEUROSCIENCE PARTNERSHIP WITH BRISTOL MYERS SQUIBB

EVOTEC RECEIVES US$ 25 M PAYMENT TO SUPPORT CONTINUED PROGRESSION OF JOINT PROGRAMS

PAYMENT FROM BRISTOL MYERS SQUIBB WILL ADVANCE FURTHER RESEARCH AND PARTNERS' JOINT PIPELINE OF PROGRAMS AIMED AT TACKLING NEUROGENERATIVE DISEASE

Source text: ID:nEQbr5NG8a

Further company coverage: EVTG.DE

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))

Recent news on Evotec SE

See all news